Royal London Asset Management LTD Organon & Co. Transaction History

Royal London Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $35,428 - $53,060	-1,654 Reduced 1.72%	94,249 $2.22 Million
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $388,968 - $502,784	12,774 Added 15.37%	95,903 $3.35 Million
Q3 2021 Oct 18, 2022	SELL	$28.63 - $35.64 $283,837 - $353,334	-9,914 Reduced 10.66%	83,129 $2.73 Million
Q3 2021 Nov 02, 2021	SELL	$28.63 - $35.64 $283,837 - $353,334	-9,914 Reduced 10.66%	83,129 $2.73 Million
Q2 2021 Oct 18, 2022	SELL	$28.45 - $38.0 $81,367 - $108,680	-2,860 Reduced 2.98%	93,043 $2.82 Million
Q2 2021 Jul 14, 2021	BUY	$28.45 - $38.0 $2.65 Million - $3.54 Million	93,043 New	93,043 $2.82 Million

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Royal London Asset Management LTD with notifications on news.